TY - JOUR
T1 - Improving Care and Empowering Adults Living with SMA
T2 - A Call to Action in the New Treatment Era
AU - Walter, Maggie C
AU - Chiriboga, Claudia
AU - Duong, Tina
AU - Goemans, Nathalie
AU - Mayhew, Anna
AU - Ouillade, Laëtitia
AU - Oskoui, Maryam
AU - Quinlivan, Ros
AU - Vázquez-Costa, Juan F
AU - Vissing, John
AU - Servais, Laurent
PY - 2021
Y1 - 2021
N2 - While Spinal Muscular Atrophy (SMA) has historically been managed with supportive measures, the emergence of innovative medicines has given those living with SMA hope for improved quality of life and has revolutionized care. Despite these advances, the use of therapies and changes in disease management strategies have focused on pediatric populations, leaving adults living with SMA, and those transitioning into adulthood, relatively neglected. Through a multi-faceted approach that gathered unbiased perspectives from clinical experts, validated insights from individuals with lived experiences, and substantiated findings with evidence from the literature, we have exposed unmet needs that are hindering the field and, ultimately, impacting care and quality of life for adults living with SMA. Here, we set new aspirations and calls to action to inspire continued research in this field, stimulate dialogue across the SMA community and inform policies that deliver effective management and care throughout an adult's journey living with SMA.
AB - While Spinal Muscular Atrophy (SMA) has historically been managed with supportive measures, the emergence of innovative medicines has given those living with SMA hope for improved quality of life and has revolutionized care. Despite these advances, the use of therapies and changes in disease management strategies have focused on pediatric populations, leaving adults living with SMA, and those transitioning into adulthood, relatively neglected. Through a multi-faceted approach that gathered unbiased perspectives from clinical experts, validated insights from individuals with lived experiences, and substantiated findings with evidence from the literature, we have exposed unmet needs that are hindering the field and, ultimately, impacting care and quality of life for adults living with SMA. Here, we set new aspirations and calls to action to inspire continued research in this field, stimulate dialogue across the SMA community and inform policies that deliver effective management and care throughout an adult's journey living with SMA.
KW - Cost of Illness
KW - Humans
KW - Muscular Atrophy, Spinal/therapy
KW - Patient Participation
KW - Quality Improvement
KW - Quality of Life
UR - http://www.scopus.com/inward/record.url?scp=85112045985&partnerID=8YFLogxK
U2 - 10.3233/JND-200611
DO - 10.3233/JND-200611
M3 - Journal article
C2 - 33646175
SN - 2214-3602
VL - 8
SP - 543
EP - 551
JO - Journal of neuromuscular diseases
JF - Journal of neuromuscular diseases
IS - 4
ER -